Home

Microb Arte literare vază bcl 2 marker in colorectal cases Periodic Fondator Flata

The BCL-2 protein family, BH3-mimetics and cancer therapy | Cell Death &  Differentiation
The BCL-2 protein family, BH3-mimetics and cancer therapy | Cell Death & Differentiation

Frontiers | Targeting Bcl-2 Proteins in Acute Myeloid Leukemia
Frontiers | Targeting Bcl-2 Proteins in Acute Myeloid Leukemia

Bcl-2, Bak, or Bax expression in localized prostate cancer and... |  Download Scientific Diagram
Bcl-2, Bak, or Bax expression in localized prostate cancer and... | Download Scientific Diagram

Loss of Bcl-G, a Bcl-2 family member, augments the development of  inflammation-associated colorectal cancer | Cell Death & Differentiation
Loss of Bcl-G, a Bcl-2 family member, augments the development of inflammation-associated colorectal cancer | Cell Death & Differentiation

Loss of Bcl-2 expression correlates with tumour recurrence in colorectal  cancer | Gut
Loss of Bcl-2 expression correlates with tumour recurrence in colorectal cancer | Gut

Bcl-2 is a critical mediator of intestinal transformation | Nature  Communications
Bcl-2 is a critical mediator of intestinal transformation | Nature Communications

Cancers | Free Full-Text | Targeting Mitochondrial Apoptosis to Overcome  Treatment Resistance in Cancer | HTML
Cancers | Free Full-Text | Targeting Mitochondrial Apoptosis to Overcome Treatment Resistance in Cancer | HTML

Frontiers | The role of BCL-2 family proteins in regulating apoptosis and  cancer therapy
Frontiers | The role of BCL-2 family proteins in regulating apoptosis and cancer therapy

BCL-XL inhibition induces an FGFR4-mediated rescue response in colorectal  cancer - ScienceDirect
BCL-XL inhibition induces an FGFR4-mediated rescue response in colorectal cancer - ScienceDirect

Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to  apoptosis in cancer | Nature Communications
Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer | Nature Communications

Docking‐based approach for identification of mutations that disrupt binding  between Bcl‐2 and Bax proteins: Inducing apoptosis in cancer cells - Raghav  - 2019 - Molecular Genetics & Genomic Medicine - Wiley Online Library
Docking‐based approach for identification of mutations that disrupt binding between Bcl‐2 and Bax proteins: Inducing apoptosis in cancer cells - Raghav - 2019 - Molecular Genetics & Genomic Medicine - Wiley Online Library

Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor  Location in Colorectal Cancer?
Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer?

Pathways of programmed cell death and its involvement with Bcl-2 family...  | Download Scientific Diagram
Pathways of programmed cell death and its involvement with Bcl-2 family... | Download Scientific Diagram

Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC,  MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or  without aspirin | PLOS ONE
Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin | PLOS ONE

BCL-2 Pathophysiology & Role in Apoptosis | Genentech Oncology
BCL-2 Pathophysiology & Role in Apoptosis | Genentech Oncology

Emerging understanding of Bcl-2 biology: Implications for neoplastic  progression and treatment - ScienceDirect
Emerging understanding of Bcl-2 biology: Implications for neoplastic progression and treatment - ScienceDirect

Cancers | Free Full-Text | Implementing Systems Modelling and Molecular  Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer  Patient-Derived Xenograft Models | HTML
Cancers | Free Full-Text | Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft Models | HTML

PROTACs are effective in addressing the platelet toxicity associated with  BCL-XL inhibitors
PROTACs are effective in addressing the platelet toxicity associated with BCL-XL inhibitors

Frontiers | Targeting the Bcl-2 Family in B Cell Lymphoma
Frontiers | Targeting the Bcl-2 Family in B Cell Lymphoma

Localization of Bcl-3 in normal colon tissue and in colon cancer. Bcl-3...  | Download Scientific Diagram
Localization of Bcl-3 in normal colon tissue and in colon cancer. Bcl-3... | Download Scientific Diagram

BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics  in therapy | SpringerLink
BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy | SpringerLink

Cancers | Free Full-Text | Targeting BCL-2 in Cancer: Advances, Challenges,  and Perspectives
Cancers | Free Full-Text | Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives

Cancers | Free Full-Text | BCL-2 Proteins in Pathogenesis and Therapy of  B-Cell Non-Hodgkin Lymphomas
Cancers | Free Full-Text | BCL-2 Proteins in Pathogenesis and Therapy of B-Cell Non-Hodgkin Lymphomas

Medicina | Free Full-Text | The Expression Pattern of Bcl-2 and Bax in the  Tumor and Stromal Cells in Colorectal Carcinoma | HTML
Medicina | Free Full-Text | The Expression Pattern of Bcl-2 and Bax in the Tumor and Stromal Cells in Colorectal Carcinoma | HTML